Please ensure Javascript is enabled for purposes of website accessibility

3 Medical Device Stocks to Invest In Now

By Keith Speights and Max Macaluso - Apr 12, 2013 at 5:15PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Which medical device stocks should investors consider now? Here are 3 great ideas.

Buy medical device stocks now? Even with the new tax imposed by Obamacare? Health care analyst Max Macaluso recently sat down with Fool contributor Keith Speights to talk about why buying medical device stocks actually makes sense. Keith discusses three stocks that he really likes in the medical device sector: Cynosure (CYNO), Edwards Lifesciences (EW -0.72%), and St. Jude Medical (STJ).

Cynosure makes laser systems for cosmetic applications such as hair removal and cellulite reduction. The company recently announced the acquisition of a rival: Palomar Medical Technologies (NASDAQ: PMTI).

Edwards stands out as a leader in the transcatheter heart valve market with its SAPIEN heart valves. The company also makes tissue heart valves and hemodynamic monitoring devices.

St. Jude Medical competes in several medical device markets, with products ranging from defibrillators to heart valves. The company also is a key player in the growing renal denervation system space.

In this video, Max and Keith discuss how each of these three stocks could be good investment opportunities.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Edwards Lifesciences Corporation Stock Quote
Edwards Lifesciences Corporation
$96.85 (-0.72%) $0.70
St. Jude Medical, Inc. Stock Quote
St. Jude Medical, Inc.
Cynosure, Inc. Stock Quote
Cynosure, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.